TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Ann: More Exceptional Clinical Results for VitroG, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. AusZeph
    426 Posts.
    clock Created with Sketch.
    17/06/10
    12:12
    Post #: 6811287
    re: Ann: More Exceptional Clinical Results fo... I'm not that happy with this ann.
    We know it has good trial results, while more never hurts it doesn't change the picture any long term holder already had of the company.
    Where is an update on negotiations with partners?
    TIS Price at posting: 19.5¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MTL RC Drilling has commenced at Roberts Hill and Mt Berghaus
right-arrow Created with Sketch.
NEWS High-grade drilling results at Coda North: impressive intercepts and major milestone achieved
right-arrow Created with Sketch.
NEWS Exceptional niobium intercepts confirmed at Stinger Discovery – dive into the latest assays
right-arrow Created with Sketch.
RCE Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
right-arrow Created with Sketch.
NEWS Full funding secured for Pular lithium project development: joint venture nears completion
right-arrow Created with Sketch.
NEWS Drilling to kick off at high-priority Bara Creek Prospect, targeting a promising epithermal system near the Bowdens Silver Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.